← All companies
PTPI
Petros Pharmaceuticals, Inc.
$0.00
+0.00 0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$127K
Revenue (TTM)
$5.11M
Net income (TTM)
$3.19M
EPS (TTM)
$7.78
P/E ratio
0.0
Dividend yield
—
Free cash flow
-$6.76M
Cash
$4.35M
Total assets
$4.39M
Gross margin
76.3%
52-week range
$0.00 – $0.03
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Director or officer change
Jun 18, 2026
8-K
Director or officer change
Jun 5, 2026
10-Q
Quarter ended 2026-03-31
May 13, 2026
10-K
Fiscal year ended 2025-12-31
Apr 15, 2026
8-K
Director or officer change
Jan 2, 2026
10-Q
Quarter ended 2025-09-30
Nov 13, 2025
8-K
Delisting notice or listing-rule failure
Nov 7, 2025
8-K
Changed accountants
Sep 5, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Regulation FD disclosure
Jun 20, 2025
8-K
Delisting notice or listing-rule failure
May 21, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
8-K
Delisting notice or listing-rule failure; Modified rights of security holders; Amended charter or bylaws
May 2, 2025
8-K
Delisting notice or listing-rule failure; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Shareholder vote results
Apr 11, 2025
8-K
Changed accountants
Apr 9, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K
Entered a material agreement; Other events
Feb 21, 2025
8-K
Entered a material agreement; Modified rights of security holders; Amended charter or bylaws
Jan 24, 2025
8-K
Triggering event accelerating an obligation
Dec 16, 2024
8-K
Shareholder vote results
Nov 21, 2024
10-Q
Quarter ended 2024-09-30
Nov 13, 2024
8-K
Director or officer change
Oct 18, 2024
8-K
Entered a material agreement; Modified rights of security holders; Amended charter or bylaws
Oct 17, 2024
8-K
Director or officer change
Oct 4, 2024
8-K
Item 5.08
Sep 19, 2024
10-Q
Quarter ended 2024-06-30
Aug 14, 2024
10-K/A
Fiscal year ended 2023-12-31
May 31, 2024
10-Q
Quarter ended 2024-03-31
May 15, 2024
10-K
Fiscal year ended 2023-12-31
Apr 1, 2024
8-K
Entered a material agreement
Mar 22, 2024
8-K
Changed accountants
Jan 12, 2024
8-K
Shareholder vote results
Dec 29, 2023
8-K
Director or officer change
Dec 28, 2023
10-Q
Quarter ended 2023-09-30
Nov 15, 2023
8-K
Amended charter or bylaws
Oct 2, 2023
8-K
Modified rights of security holders; Director or officer change; Amended charter or bylaws; Shareholder vote results
Sep 15, 2023
8-K
Amended charter or bylaws
Aug 15, 2023
10-Q
Quarter ended 2023-06-30
Aug 14, 2023
8-K
Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events
Jul 13, 2023
10-Q
Quarter ended 2023-03-31
May 15, 2023